GlobalData on MSN2d
MSD and Eisai’s LEAP gastroesophageal cancer trial sees mixed success
MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...
Targeted Oncology24d
Novel Therapies and Combinations Lead the Way in Women’s Cancers in 2024
2,3 Efficacy findings from the KEYNOTE-868/NRG- GY018 trial (NCT03914612) led to the FDA’s approval of pembrolizumab for endometrial carcinoma. The trial stratified 222 patients to the MMR- deficient ...
Pharmaceutical Technology25d
UK MHRA approves MSD’s pulmonary arterial hypertension therapy
MSD acquired the therapy from Acceleron Pharma. Credit: Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. MSD has received ...
Reuters27d
Merck wins UK approval for lung disease drug acquired in $11 billion deal
Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's (MRK.N), opens new tab therapy to treat a rare lung condition, marking another ...
Morningstar27d
MS Emerging Markets Debt MSD
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...